MIRAGEN Trademark

Trademark Overview


On Tuesday, August 1, 2017, a trademark application was filed for MIRAGEN with the United States Patent and Trademark Office. The USPTO has given the MIRAGEN trademark a serial number of 87551279. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 30, 2024. This trademark is owned by miRagen Therapeutics, Inc.. The MIRAGEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of therapeutic drugs for treatment of cardiovascular and muscle diseases, cancers, fibrosis, and autoimmune, inflammatory, and neurodegenerative conditions
miragen

General Information


Serial Number87551279
Word MarkMIRAGEN
Filing DateTuesday, August 1, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 30, 2024
Registration Number5407461
Registration DateTuesday, February 20, 2018
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, December 5, 2017

Trademark Statements


Description of MarkThe mark consists of the literal element "MiRagen" in stylized letters. The letters are lowercase except for the "R" which is uppercase. The letter "i" has a grey dot and also forms the left side of the letter "R". "miR" is in green font and "agen" is in grey font.
In Another Form StatementThe mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/01/2006
In Another Form StatementThe mark was first used in commerce in a different form other than that sought to be registered at least as early as 07/13/2007
Indication of Colors claimedThe color(s) green and grey is/are claimed as a feature of the mark.
Goods and ServicesResearch and development of therapeutic drugs for treatment of cardiovascular and muscle diseases, cancers, fibrosis, and autoimmune, inflammatory, and neurodegenerative conditions

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 30, 2024
Primary Code042
First Use Anywhere DateMonday, July 24, 2017
First Use In Commerce DateMonday, July 24, 2017

Trademark Owner History


Party NamemiRagen Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301

Party NamemiRagen Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301

Party NamemiRagen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301

Trademark Events


Event DateEvent Description
Friday, August 4, 2017NEW APPLICATION ENTERED
Wednesday, November 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 5, 2017PUBLISHED FOR OPPOSITION
Tuesday, December 5, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 20, 2018REGISTERED-PRINCIPAL REGISTER
Friday, June 11, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Friday, August 4, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 1, 2017ASSIGNED TO EXAMINER
Thursday, November 2, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 11, 2021WITHDRAWAL OF ATTORNEY GRANTED
Monday, February 20, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, August 30, 2024CANCELLED SEC. 8 (6-YR)